参考文献/References:
[1] Benjafield AV,Ayas NT,Eastwood PR,et al. Estimation of the global prevalence and burden of obstructive sleep apnoea:a literature-based analysis[J]. Lancet Respir Med ,2019,7(8):687-698.
[2] Shiina K. Obstructive sleep apnea-related hypertension:a review of the literature and clinical management strategy[J]. Hypertens Res,2024,47(11):3085-3098.
[3] Cai A,Wang L,Zhou Y. Hypertension and obstructive sleep apnea[J]. Hypertens Res,2016,39(6):391-395.
[4] Heffernan A,Duplancic D,Kumric M,et al. Metabolic crossroads:unveiling the complex interactions between obstructive sleep apnoea and metabolic syndrome[J]. Int J Mol Sci,2024,25(6):3243.
[5] Kwon Y,Tzeng W S,Seo J,et al. Obstructive sleep apnea and hypertension;critical overview[J]. Clin Hypertens,2024,30(1):19.
[6] Ou YH,Tan A,Lee CH. Management of hypertension in obstructive sleep apnea[J]. Am J Prev Cardiol ,2023,13:100475.
[7] Brown J,Yazdi F,Jodari-Karimi M,et al. Obstructive sleep apnea and hypertension:updates to a critical relationship[J]. Curr Hypertens Rep,2022,24(6):173-184.
[8] Mashaqi S,Gozal D. Obstructive sleep apnea and systemic hypertension:gut dysbiosis as the mediator?[J]. J Clin Sleep Med,2019,15(10):1517-1527.
[9] Ganesh BP,Nelson JW,Eskew JR,et al. Prebiotics,probiotics,and acetate supplementation prevent hypertension in a model of obstructive sleep apnea[J]. Hypertension,2018,72(5):1141-1150.
[10] Xue J,Allaband C,Zhou D,et al. Influence of intermittent hypoxia/hypercapnia on atherosclerosis,gut microbiome,and metabolome[J]. Front Physiol,2021,12:663950.
[11] Munir SS,Sert Kuniyoshi FH,Singh P,et al. Is the gut microbiome implicated in the excess risk of hypertension associated with obstructive sleep apnea? A contemporary review[J]. Antioxidants(Basel),2023,12(4):866.
[12] Tang WHW,B?ckhed F,Landmesser U,et al. Intestinal microbiota in cardiovascular health and disease:JACC state-of-the-art review[J]. J Am Coll Cardiol,2019,73(16):2089-2105.
[13] Takeda Y,Itaya-Hironaka A,Yamauchi A,et al. Intermittent hypoxia upregulates the renin and Cd38 mRNAs in renin-producing cells via the downregulation of miR-203[J]. Int J Mol Sci,2021,22(18):10127.
[14] Yan D,Zou X,Li X,et al. Screening parameters for diagnosing primary aldosteronism in patients with moderate to severe obstructive sleep apnea hypopnea syndrome and resistant hypertension[J]. Front Cardiovasc Med,2024,11:1383567.
[15] Ayyaswamy S,Shi H,Zhang B,et al. Obstructive sleep apnea-induced hypertension is associated with increased gut and neuroinflammation[J]. J Am Heart Assoc,2023,12(11):e029218.
[16] Liu J,Li T,Wu H,et al. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4+ T cell induced-type I inflammation[J]. Biomed Pharmacother,2019,112:108580.
[17] Alterki A,Abu-Farha M,Al Shawaf E,et al. Investigating the relationship between obstructive sleep apnoea,inflammation and cardio-metabolic diseases[J]. Int J Mol Sci,2023,24(7):6807.
[18] Nanduri J,Wang N,Yuan G,et al. Intermittent hypoxia degrades HIF-2α via calpains resulting in oxidative stress:implications for recurrent apnea-induced morbidities[J]. Proc Natl Acad Sci U S A,2009,106(4):1199-1204.
[19] 黎宁,吴峰,胡涛. 缺氧诱导因子-1α与阻塞性睡眠呼吸暂停相关高血压的研究进展[J]. 实用临床医药杂志,2023,27(7):138-142.
[20] Liu L,Wang Y,Hong L,et al. Obstructive sleep apnea and hypertensive heart disease:from pathophysiology to therapeutics[J]. Rev Cardiovasc Med,2023,24(12):342.
[21] Davis GK,Fehrenbach DJ,Madhur MS. Interleukin 17A:key player in the pathogenesis of hypertension and a potential therapeutic target[J]. Curr Hypertens Rep,2021,23(3):13.
[22] Kario K,Hettrick DA,Prejbisz A,et al. Obstructive sleep apnea-induced neurogenic nocturnal hypertension:a potential role of renal denervation?[J]. Hypertension,2021,77(4):1047-1060.
[23] Pio-Abreu A,Moreno H Jr ,Drager LF. Obstructive sleep apnea and ambulatory blood pressure monitoring:current evidence and research gaps[J]. J Hum Hypertens,2021,35(4):315-324.
[24] Kou C,Zhao X,Lin X,et al. Effect of different treatments for obstructive sleep apnoea on blood pressure[J]. J Hypertens,2022,40(6):1071-1084.
[25] Baran R,Grimm D,Infanger M,et al. The effect of continuous positive airway pressure therapy on obstructive sleep apnea-related hypertension[J]. Int J Mol Sci,2021,22(5):2300.
[26] 司胜勇,李治菁,韩肖,等. 高血压合并阻塞性睡眠呼吸暂停低通气综合征患者的临床特点及血液流变学指标变化分析[J]. 中外医学研究,2023,21(30):61-64.
[27] 国家卫生健康委高血压诊疗研究重点实验室学术委员会,国家卫生健康委高血压诊疗研究重点实验室,新疆维吾尔自治区人民医院高血压中心. 2023阻塞性睡眠呼吸暂停相关性高血压临床诊断和治疗专家共识[J]. 中华高血压杂志,2023,31(12):1142-1155.
[28] Wang X,Guan L,Wu C,et al. Continuous positive airway pressure may improve hypertension in patients with obstructive sleep apnea-hypopnea syndrome by inhibiting inflammation and oxidative stress[J]. Arch Med Sci,2022,19(1):237-241.
[29] Korostovtseva LS,Ionov MV,Shcherbakova EA,et al. Progression of obstructive sleep apnoea after renal denervation is not associated with hypertension exaggeration[J]. BMC Pulm Med,2023,23(1):467.
[30] Lu D,Wang J,Zhang H,et al. Renal denervation improves chronic intermittent hypoxia induced hypertension and cardiac fibrosis and balances gut microbiota[J]. Life Sci,2020,262:118500.
[31] Zhang J,Chen Z,Deng Y,et al. Impacts of renal denervation on blood pressure in patients with obstructive sleep apnea[J]. Sleep Breath,2024,28(5):2135-2141.
[32] Xu H,Wang J,Cai J,et al. Protective effect of Lactobacillus rhamnosus GG and its supernatant against myocardial dysfunction in obese mice exposed to intermittent hypoxia is associated with the activation of Nrf2 pathway[J]. Int J Biol Sci,2019,15(11):2471-2483.
[33] Badran M,Mashaqi S,Gozal D. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea[J]. Expert Opin Ther Targets,2020,24(12):1263.
[34] Liu M,Galli G,Wang Y,et al. Novel therapeutic targets for hypoxia-related cardiovascular diseases:the role of HIF-1[J]. Front Physiol,2020,11:774.
[35] Yuan G,Peng YJ,Khan SA,et al. H2S production by reactive oxygen species in the carotid body triggers hypertension in a rodent model of sleep apnea[J]. Sci Signal,2016,9(441):ra80.
[36] Guo C,Zhang M,Su W,et al. miR-199a-5p relieves obstructive sleep apnea syndrome-related hypertension by targeting HIF-1α[J]. J Immunol Res,2022,2022:7236647.
[37] Hynes D,Mansfield D. Diagnosis and management of obstructive sleep apnoea in adults[J]. Aust Prescr,2024,47(2):52-56.
[38] 赵临丽,于洪跃,顾宁. 高血压合并阻塞性睡眠呼吸暂停低通气综合征中西医研究进展[J]. 中西医结合心脑血管病杂志,2023,21(21):3966-3968.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(3):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(3):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(3):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(3):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(3):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(3):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(3):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]